GPFA
GLSI icon

Game Plan Financial Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Game Plan Financial Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$3.99K – 402
2024
Q1 		$3.99K Hold
200
– – ﹤0.01% 316
2023
Q4 		$2.1K Buy
+200
New +$2K ﹤0.01% 335

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Game Plan Financial Advisors's GLSI Position: Q2 2024 in Review

Game Plan Financial Advisors sold out of Greenwich LifeSciences (GLSI) in Q2 2024, closing a stake of 200 shares — an estimated $3.99K sold.

Game Plan Financial Advisors first reported a position in GLSI in Q4 2023 and held it in 2 quarters. The position peaked at $3.99K in Q1 2024. 34 funds tracked by Wall St. Rank hold GLSI as of Q2 2024.

  • Game Plan Financial Advisors reported no remaining Greenwich LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Game Plan Financial Advisors sold 200 Greenwich LifeSciences shares in Q2 2024, an estimated $3.99K.
  • Game Plan Financial Advisors first reported a position in Greenwich LifeSciences in Q4 2023 and held it in 2 quarters.
  • Game Plan Financial Advisors's Greenwich LifeSciences position peaked at $3.99K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2024.

Based on Game Plan Financial Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.